C. Tomescu

发表

Identification of the predominant human NK cell effector subset mediating ADCC against HIV‐infected targets coated with BNAbs or plasma from PLWH

L. Montaner, E. Papasavvas, K. Mounzer, 2021, European journal of immunology.

Persons who inject drugs (PWID) retain functional NK cells, dendritic cell stimulation, and adaptive immune recall responses despite prolonged opioid use

L. Montaner, D. Metzger, L. Azzoni, 2020, Journal of leukocyte biology.

IFN-α augments NK-mediated antibody-dependent cellular cytotoxicity (ADCC) of HIV-1 infected autologous CD4+ T cells regardless of MHC-I downregulation.

L. Montaner, P. Tebas, C. Tomescu, 2017, AIDS.

IFN-α augments natural killer-mediated antibody-dependent cellular cytotoxicity of HIV-1-infected autologous CD4+ T cells regardless of major histocompatibility complex class 1 downregulation.

L. Montaner, P. Tebas, C. Tomescu, 2017, AIDS.

Lysis of HIV-1-infected autologous CD4+ primary T cells by interferon-alpha-activated NK cells requires NKp46 and NKG2D

L. Montaner, D. Mavilio, C. Tomescu, 2015, AIDS.

Retention of viability, cytotoxicity, and response to IL‐2, IL‐15, or IFN‐α by human NK cells after CD107a degranulation

L. Montaner, V. Maino, C. Tomescu, 2009, Journal of leukocyte biology.

A Correlate of HIV-1 Control Consisting of Both Innate and Adaptive Immune Parameters Best Predicts Viral Load by Multivariable Analysis in HIV-1 Infected Viremic Controllers and Chronically-Infected Non-Controllers

L. Montaner, J. Kostman, K. Mounzer, 2014, PloS one.

Impact of protective killer inhibitory receptor/human leukocyte antigen genotypes on natural killer cell and T-cell function in HIV-1-infected controllers

M. Carrington, F. Duh, L. Montaner, 2012, AIDS.

Baseline Viral Load and Immune Activation Determine the Extent of Reconstitution of Innate Immune Effectors in HIV-1-Infected Subjects Undergoing Antiretroviral Treatment12

L. Montaner, J. Kostman, K. Mounzer, 2007, The Journal of Immunology.

Subjects Undergoing Antiretroviral Innate Immune Effectors in HIV-1-Infected Determine the Extent of Reconstitution of Baseline Viral Load and Immune Activation

L. Montaner, J. Kostman, K. Mounzer, 2007 .

Evidence for the innate immune response as a correlate of protection in human immunodeficiency virus (HIV)‐1 highly exposed seronegative subjects (HESN)

L. Montaner, S. Abdulhaqq, C. Tomescu, 2011, Clinical and experimental immunology.

Increased plasmacytoid dendritic cell maturation and natural killer cell activation in HIV-1 exposed, uninfected intravenous drug users

M. Carrington, F. Duh, L. Montaner, 2010, AIDS.

Innate Activation of MDC and NK Cells in High-Risk HIV-1–Exposed Seronegative IV-Drug Users Who Share Needles When Compared With Low-Risk Nonsharing IV-Drug User Controls

L. Montaner, D. Metzger, G. Tomaras, 2015, Journal of acquired immune deficiency syndromes.

BCL6 Inhibitor-Mediated Downregulation of Phosphorylated SAMHD1 and T Cell Activation Are Associated with Decreased HIV Infection and Reactivation

L. Montaner, L. Azzoni, B. Howell, 2018, Journal of Virology.

Anti-α4β7 therapy targets lymphoid aggregates in the gastrointestinal tract of HIV-1–infected individuals

H. Ueno, L. Montaner, T. Schacker, 2018, Science Translational Medicine.

Surface Downregulation of Major Histocompatibility Complex Class I, PE-CAM, and ICAM-1 following De Novo Infection of Endothelial Cells with Kaposi's Sarcoma-Associated Herpesvirus

D. Kedes, C. Tomescu, W. K. Law, 2003, Journal of Virology.

Intracellular Kaposi's Sarcoma-Associated Herpesvirus Load Determines Early Loss of Immune Synapse Components

D. Kedes, Laura A. Adang, C. Tomescu, 2007, Journal of Virology.

Anti-α4β7 therapy targets lymphoid aggregates in the gastrointestinal tract of HIV-1–infected individuals

H. Ueno, L. Montaner, T. Schacker, 2018, Science Translational Medicine.

CD32 is expressed on cells with transcriptionally active HIV but does not enrich for HIV DNA in resting T cells

D. Hazuda, D. Richman, J. Martinez-Picado, 2018, Science Translational Medicine.

NK Cell Lysis of HIV-1-Infected Autologous CD4 Primary T Cells: Requirement for IFN-Mediated NK Activation by Plasmacytoid Dendritic Cells1

L. Montaner, V. Maino, C. Tomescu, 2007, The Journal of Immunology.

S100A14 Is Increased in Activated NK Cells and Plasma of HIV-Exposed Seronegative People Who Inject Drugs and Promotes Monocyte–NK Crosstalk

L. Montaner, D. Speicher, D. Metzger, 2019, Journal of acquired immune deficiency syndromes.

Inability of Plasmacytoid Dendritic Cells To Directly Lyse HIV-Infected Autologous CD4+ T Cells despite Induction of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand

L. Montaner, E. Papasavvas, M. Pistilli, 2009, Journal of Virology.

Siglec-9 defines and restrains a natural killer subpopulation highly cytotoxic to HIV-infected cells

D. Weiner, M. Betts, C. Shikuma, 2021, PLoS pathogens.

The role of CD32 during HIV-1 infection

R. Siliciano, J. Margolick, L. Montaner, 2018, Nature.

Majority of the latent reservoir resides in CD32a negative CD4+ T cells

R. Siliciano, J. Margolick, L. Montaner, 2017 .

Inability of Plasmacytoid Dendritic Cells To Directly Lyse HIV-Infected Autologous CD4 (cid:1) T Cells despite Induction of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (cid:1)

L. Montaner, E. Papasavvas, M. Pistilli, 2010 .

This information is current as Plasmacytoid Dendritic Cells IFN-Mediated NK Activation by CD4 Primary T Cells: Requirement for NK Cell Lysis of HIV-1-Infected Autologous

V. Maino, J. Montaner, C. Tomescu, 2013 .